Spring Call 2022 - closed
MRC CiC/Leicester Drug Discovery and Diagnostics (LD3) Spring Call - closed
Accelerating translational research at the University of Leicester
Elevator pitch for top-ranked PIs and funding decision: TBC
We are looking to fund innovative, translational projects at various stages of development, from target validation/Proof of Concept studies to pre-clinical testing.
Priority areas should accelerate innovative translational research towards the development of novel medicines, therapies, devices, diagnostic tests and precision medicine approaches in Leicester.
Please note: MRC terms mean that this cannot be used for bridging salary funding between grants.
Award value: up to 70k.
Duration: projects should be up to 12 months and must finish by end of July 2023.
For more information about the award and application process, please contact: Dr Carl Edwards, LD3 Research Manager email@example.com.